CMHC 2013 Cardiometabolic Health Congress: Home
Home Home  •  Site Map  •  Search  •  Useful Links
Hypertensionj

Quick Links

Join Us On CMHC Facebook CMHC Twitter CMHC LinkedIn CMHC BLOG YouTube Subscribe CMHC Register Now!
Cardiometabolic Health Congress: CME conference on hypertension, dyslipidemia, obesity, cardiovascular risk, atherosclerosis, kidney disease, metabolic syndrome, cardiovascular disease, cardiometabolic risk, educational meeting



Distinguished Faculty

Biography: Marc Sabatine, MD, MPH

Marc Sabatine, MD, MPHMarc S. Sabatine, MD, MPH is the Chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group, an Associate Physician in Cardiovascular Medicine at Brigham and Women’s Hospital (BWH), and an Associate Professor of Medicine at Harvard Medical School.

Dr. Sabatine graduated magna cum laude from Harvard College and received his medical degree magna cum laude from Harvard Medical School. He did his Internal Medicine residency and Cardiology clinical fellowship at the Massachusetts General Hospital and his research fellowship at the TIMI Study Group at BWH. He received a Master of Public Health degree from the Harvard School of Public Health. Dr. Sabatine is board certified in Internal Medicine and in Cardiology, and he attends on the general cardiology services and in the coronary care unit at both Brigham and Women’s Hospital and the Massachusetts General Hospital. He is the Editor of Pocket Medicine, a widely used handbook of internal medicine. He is a member of the American Heart Association, a Fellow of the American College of Cardiology, and a Fellow of the European Society of Cardiology.

As Chairman of the TIMI Study Group, Dr. Sabatine leads an Academic Research Organization that includes over a dozen staff cardiologists and whose mission statement is to advance the knowledge and care of patients suffering from cardiovascular disease and its risk factors by performing clinical trials. To that end, Dr. Sabatine has led several large-scale, international, randomized controlled trials of novel antithrombotic pharmacotherapies. He was also a pioneer in the multimarker approach to risk stratification and has several NIH grants supporting the application of proteomics and metabolomics for discovery of novel biomarkers. He has a long-standing interest in pharmacogenetics and has made seminal observations on the impact of genetic polymorphisms on the pharmacologic and clinical response to antiplatelet therapy. Dr. Sabatine has published extensively in these fields and has authored over 100 original research, peer-reviewed articles including in the New England Journal of Medicine, JAMA, and the Lancet, in addition to numerous other review articles and book chapters. He is the recipient of multiple awards including the American College of Cardiology Zipes Distinguished Young Scientist Award.

< Back